Korro Bio Statistics
Share Statistics
Korro Bio has 9.39M
shares outstanding. The number of shares has increased by 1.25%
in one year.
| Shares Outstanding | 9.39M |
| Shares Change (YoY) | 1.25% |
| Shares Change (QoQ) | 0.22% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 147 |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -4.06 and the forward
PE ratio is -1.49.
Korro Bio's PEG ratio is
0.05.
| PE Ratio | -4.06 |
| Forward PE | -1.49 |
| PS Ratio | 149.54 |
| Forward PS | 0.9 |
| PB Ratio | 2.12 |
| P/FCF Ratio | -4.36 |
| PEG Ratio | 0.05 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Korro Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.79,
with a Debt / Equity ratio of 0.28.
| Current Ratio | 8.79 |
| Quick Ratio | 8.79 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | -0.51 |
| Debt / FCF | -0.57 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $21,836.54 |
| Profits Per Employee | $-803,663.46 |
| Employee Count | 104 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 141K |
| Effective Tax Rate | -0.17% |
Stock Price Statistics
The stock price has increased by -68.16% in the
last 52 weeks. The beta is 2.66, so Korro Bio's
price volatility has been higher than the market average.
| Beta | 2.66 |
| 52-Week Price Change | -68.16% |
| 50-Day Moving Average | 19.56 |
| 200-Day Moving Average | 38.44 |
| Relative Strength Index (RSI) | 54.38 |
| Average Volume (20 Days) | 93,829 |
Income Statement
In the last 12 months, Korro Bio had revenue of 2.27M
and earned -83.58M
in profits. Earnings per share was -9.37.
| Revenue | 2.27M |
| Gross Profit | -1.29M |
| Operating Income | -91.91M |
| Net Income | -83.58M |
| EBITDA | -88.34M |
| EBIT | -91.91M |
| Earnings Per Share (EPS) | -9.37 |
Full Income StatementBalance Sheet
The company has 55.64M in cash and 44.77M in
debt, giving a net cash position of 10.88M.
| Cash & Cash Equivalents | 55.64M |
| Total Debt | 44.77M |
| Net Cash | 10.88M |
| Retained Earnings | -266.59M |
| Total Assets | 226.24M |
| Working Capital | 116.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -60.07M
and capital expenditures -17.9M, giving a free cash flow of -77.98M.
| Operating Cash Flow | -60.07M |
| Capital Expenditures | -17.9M |
| Free Cash Flow | -77.98M |
| FCF Per Share | -8.74 |
Full Cash Flow StatementMargins
Gross margin is -56.98%, with operating and profit margins of -4047.12% and -3680.36%.
| Gross Margin | -56.98% |
| Operating Margin | -4047.12% |
| Pretax Margin | -3674.15% |
| Profit Margin | -3680.36% |
| EBITDA Margin | -3890.14% |
| EBIT Margin | -4047.12% |
| FCF Margin | -3433.55% |
